Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
While its a functional disorder without structural damage, BPC-157 may provide symptom relief by: Modulating nitric oxide and serotonin activity Reducing visceral pain and inflammation Normalizing motility through enteric nervous system regulation BPC-157s neural and anti-inflammatory support makes it a candidate for addressing both the gut-brain axis and local irritation in IBS patients
The Billon 2025 paper (PMID 41421047) introduced SLU-PP-915 as an "orally active" sibling specifically because the parent SLU-PP-332 "lacks oral bioavailability." Despite that, the most common vendor formats are oral capsules and tablets products without published evidence that they produce systemic ERR agonism in humans
The clinical picture is clear on the deficiency side
VAT P U R E T R U S T E D V E G A N + Purest Formulas Here at Epigenetics, the quality and purity of each ingredient is integral to our development of effective, bioavailable formulas
